Online Inquiry

Biosensor Development Service

Due to its unique advantages, the CRISPR-Cas system has been used to develop biosensors. CD BioSciences, a premier biotechnology company, is committed to providing you with CRISPR biosensor development service based on the CRISPR-Cas system.

Biosensors

A biosensor is an instrument used to detect the presence or concentration of biological analytes, biological structures or microorganisms. It consists of three main components: an identification element that identifies the analyte and generates a signal, a signal sensor, and a reader that measures and quantifies the received signal.

Biosensor

CRISPR-Cas System-Based Biosensors

The CRISPR-Cas system is an adaptive immune defense system for bacteria and archaea. It can be used not only for gene editing, but also shows great potential for analytes detection.

The discovery of the anticut properties of CRISPR V-type effectors has made the CRISPR-Cas system a potential high-precision biometric tool. In CRISPR biosensing technology, Cas effector proteins are used as highly specific In CRISPR biosensing, Cas effector proteins are used as highly specific sequence recognition elements, which can be used in combination with different biosensing mechanisms for rapid and sensitive detection of various analytes with high specificity.

Our Services

Utilizing the CRISPR-Cas system's ability to specifically identify and incidentally cleave, CD BioSciences offers biosensor development service for different detection needs. In addition, we also provide services for the detection of various analytes such as nucleic acids, protein biomarkers, metal ions, and small molecules.

Our DeteCasTM platform offers diferent biosensors development service, including but not limited to the followings.

Nucleic Acid Biosensor Development Service

Nucleic Acid Biosensor Development Service

  • Constant Temperature Amplification of Target Nucleic Acids
  • Design of Efficient Signal Reporter Molecules
  • Preference of Cas Effector Proteins
  • Optimization of gRNA Design
Protein Biosensor Development Service

Protein Biosensor Development Service

  • Design of dsDNA Containing T7 Promoter Sequence
  • Preference of Cas Effector Proteins
  • Design of DNA Activator
  • Selection of Different Signal Amplification Strategies
Metal Ion Biosensor Development Service

Metal Ion Biosensor Development Service

  • Design of Functional Nucleic Acids
  • Optimization of gRNA Design
  • Selection of Different Signal Amplification Strategies
  • Preference of Cas Effector Proteins
  • Design of DNA Activator
Small Molecule Biosensor Development Service

Small Molecule Biosensor Development Service

  • Designing Identification Components
  • Preference of Cas Effector Proteins
  • Optimization of gRNA Design
  • Design of Efficient Signal Reporter Molecules

Applications

Food Safety Detection

Food Safety Detection

Disease Diagnosis

Disease Diagnosis

Environmental Monitoring

Environmental Monitoring

Process of Our Service

Process of Our Service

Advantages of Our Service

• High Flexibility

Only the given gRNA sequence needs to be changed for different gene targets.

• High Specificity

Single-base resolution detection of biosensors is fully possible.

• High Sensitivity

Target analytes can be detected at concentrations as low as 10-18 mol/L.

CD BioSciences provides affordable, qualified and hassle-free biosensor development service to our global clients. We guarantee on-time delivery of results. We are available to you 24 hours a day, so please feel free to contact us.

References

  1. Xu, W.J., et al. Pathogen detection based on CRISPR/Cas biosensing principal bacteria detection technology. Chinese Journal of Biological Engineering. 2021, 41(8): 8.
  2. Xie, S.Y., et al. Advancing sensing technology with CRISPR: from the detection of nucleic acids to a broad range of analytes – A Review. Analytica Chimica Acta. 2021: 338848.
  3. Chen, Y.J., et al. Applying CRISPR/Cas system as a signal enhancer for DNAzyme-based lead ion detection. Analytica Chimica Acta. 2021, (1192): 339356.
For research use only. Not intended for any clinical use.

Online Inquiry

Related Services

Copyright © CD BioSciences. All rights reserved.